1
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Naomi Rodrig, 2 years ago
The BRAF inhibitors vemurafenib and dabrafenib, currently approved for use in advanced melanoma, are also effective in a subset of lung adenocarcinoma patients with BRAF mutations, according to a retrospective European trial presented at the European Lung Cancer Conference (ELCC) held in Geneva, Switzerland. 
Alyssa Cayton, 2 years ago
Best available data on the safety of influenza vaccination during pregnancy on foetal development were analysed in this systematic review.
Pearl Toh, 2 months ago
An extrafine fixed triple therapy, comprising the long-acting muscarinic antagonist (LAMA) glycopyrronium bromide (GB), the long-acting β₂-agonist (LABA) formoterol fumarate (FF), and the inhaled corticosteroid (ICS) beclometasone dipropionate (BDP), is superior to the LAMA tiotropium alone in reducing exacerbations and improving lung function in patients with symptomatic chronic obstructive pulmonary disease (COPD), according to the TRINITY* trial.
Elaine Soliven, 2 months ago
Benzodiazepine use appears to be associated with increased risk of pneumonia among patients with Alzheimer’s disease, according to a recent study.